Smith & Howard Wealth Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-39,140
Closed -$250K 49
2018
Q2
$250K Hold
39,140
0.11% 43
2018
Q1
$273K Buy
39,140
+2,600
+7% +$30.3K 0.12% 38
2017
Q4
$461K Hold
36,540
0.22% 28
2017
Q3
$434K Buy
36,540
+15,110
+71% +$224K 0.21% 32
2017
Q2
$321K Buy
21,430
+5,000
+30% +$66.7K 0.15% 37
2017
Q1
$157K Sell
16,430
-931
-5% -$7.86K 0.08% 57
2016
Q4
$154K Hold
17,361
0.08% 45
2016
Q3
$149K Buy
+17,361
New +$138K 0.08% 40
2016
Q2
Sell
-17,361
Closed -$152K 52
2016
Q1
$152K Hold
17,361
0.06% 61
2015
Q4
$163K Hold
17,361
0.08% 63
2015
Q3
$168K Buy
+17,361
New +$183K 0.08% 51
2014
Q1
Sell
-931
Closed -$8K 146
2013
Q4
$8K Hold
931
﹤0.01% 209
2013
Q3
$4K Hold
931
﹤0.01% 228
2013
Q2
$7K Buy
+931
New +$6.51K ﹤0.01% 188

Other funds holding MDXG

Smith & Howard Wealth Management's MDXG Position: Q3 2018 in Review

Smith & Howard Wealth Management sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 39,140 shares — an estimated $250K sold.

Smith & Howard Wealth Management first reported a position in MDXG in Q2 2013 and held it in 14 quarters. The position peaked at $461K in Q4 2017. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

  • Smith & Howard Wealth Management reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
  • Smith & Howard Wealth Management sold 39,140 MiMedx Group shares in Q3 2018, an estimated $250K.
  • Smith & Howard Wealth Management first reported a position in MiMedx Group in Q2 2013 and held it in 14 quarters.
  • Smith & Howard Wealth Management's MiMedx Group position peaked at $461K in Q4 2017.
  • 186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Smith & Howard Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.